510(k) K213348

BOND MMR Antibody Panel by Leica Biosystems Newcastle, Ltd. — Product Code PZJ

K213348 is an FDA 510(k) premarket notification submitted by Leica Biosystems Newcastle, Ltd. for the device "BOND MMR Antibody Panel". The FDA issued a decision of Substantially Equivalent on Feb 21, 2023. The device falls under product code PZJ (Lynch Syndrome Test System), a Class II device regulated under 21 CFR 864.1866. Leica Biosystems Newcastle, Ltd. has 2 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Feb 21, 2023
Date Received
Oct 8, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Lynch Syndrome Test System
Device Class
Class II
Regulation Number
864.1866
Review Panel
PA
Submission Type
510(k)

The Lynch syndrome test system is used to identify loss of DNA mismatch repair proteins or microsatellite instability in tumor tissue from cancer patients for the purpose of identifying patients who may benefit from additional testing for the inherited cancer predisposition Lynch Syndrome

Need the full FDA record for Leica Biosystems Newcastle, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K213348. Report a data issue: hello@regdatalab.com.